Low HDL-C Level Is Associated with the Development of Intracranial Artery Stenosis: Analysis from the Chinese IntraCranial AtheroSclerosis (CICAS) Study

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Qian, Yining ^a   Pu, Yuehua ^b   Liu, Liping ^b   Wang, David Z ^c   Zhao, Xingquan ^b   Wang, Chunxue ^b   Wang, Yilong ^b   Liu, Gaifen ^b   Pan, Yuesong ^b   Wang, Yongjun ^b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BRAIN ATHEROSCLEROSIS; BRAIN ISCHEMIA; CHINESE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; HUMAN; MAGNETIC RESONANCE ANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; NEUROIMAGING; OCCLUSIVE CEREBROVASCULAR DISEASE; PREDICTIVE VALUE; BLOOD; CHINA; COHORT ANALYSIS; INTRACRANIAL ARTERIOSCLEROSIS; NONPARAMETRIC TEST; PATHOLOGY; PROSPECTIVE STUDY; RISK FACTOR; STROKE;

CHINA; CHOLESTEROL, HDL; COHORT STUDIES; HUMANS; INTRACRANIAL ARTERIOSCLEROSIS; MAGNETIC RESONANCE ANGIOGRAPHY; PROSPECTIVE STUDIES; RISK FACTORS; STATISTICS, NONPARAMETRIC; STROKE;

EID: 84877864653     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0064395     Document Type: Article

References (32)

1. Gorelick PB, Wong KS, Bae H-J, Pandey DK, (2008) Large artery intracranial occlusive disease- A large worldwide burden but a relatively neglected frontier. Stroke 39: 2396-2399.
2. Sacco RL KD, Zamanillo M, (1995) Race-ethnic differences in stroke risk-factors among hospitalized-patients with cerebral infarction- the Northern manhattan stroke study. Neurology 45: 659-663.
3. Suri MF, Johnston SC, (2009) Epidemiology of intracranial stenosis. J Neuroimaging 19 Suppl 1: 11S-16S.
4. Wong KS, Li H, Chan YL, Ahuja A, Lam WWM, et al. (2000) Use of transcranial Doppler ultrasound to predict outcome in patients with intracranial large-artery occlusive disease. Stroke 31: 2641-2647.
5. Huang YN, Gao S, Li SW, Huang Y, Li JF, et al. (1997) Vascular lesions in Chinese patients with transient ischemic attacks. Neurology 48: 524-525.
6. Kim JS, Kang DW, Kwon SU, (2005) Intracranial atherosclerosis: incidence, diagnosis and treatment. J Clin Neurol 1: 1-7.
7. Bang OY, Kim JW, Lee JH, Lee MA, Lee PH, et al. (2005) Association of the metabolic syndrome with intracranial atherosclerotic stroke. Neurology 65: 296-298.
8. Sacco RL, Benjamin EJ, Broderick JP, Dyken M, Easton JD, et al. (1997) Risk factors. Stroke 28: 1507-1517.
9. Arenillas JF, Molina CA, Chacon P, Rovira A, Montaner J, et al. (2004) High lipoprotein (a), diabetes, and the extent of symptomatic intracranial atherosclerosis. Neurology 63: 27-32.
10. Zhao WH, Zhang J, Zhai Y, You Y, Man QQ, et al. (2007) Blood lipid profile and prevalence of dyslipidemia in Chinese adults. Biomed Environ Sci 20: 329-335.
11. Maron DJ, (2000) The epidemiology of low levels of high-density lipoprotein cholesterol in patients with and without coronary artery disease. Am J Cardiol 86: 11L-14L.
12. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) (2001) JAMA 285: 2486-2497.
13. Samuels OB, Joseph GJ, Lynn MJ, Smith HA, Chimowitz MI, (2000) A standardized method for measuring intracranial arterial stenosis. AJNR Am J Neuroradiol 21: 643-646.
14. Nederkoorn PJ, van der Graaf Y, Eikelboom BC, van der Lugt A, Bartels LW, et al. (2002) Time-of-flight MR angiography of carotid artery stenosis: does a flow void represent severe stenosis? AJNR Am J Neuroradiol 23: 1779-1784.
15. Wong LK, (2006) Global burden of intracranial atherosclerosis. Int J Stroke 1: 158-159.
16. Soyama Y, Miura K, Morikawa Y, Nishijo M, Nakanishi Y, et al. (2003) High-density lipoprotein cholesterol and risk of stroke in Japanese men and women: the Oyabe Study. Stroke 34: 863-868.
17. Wannamethee SG, Shaper AG, Ebrahim S, (2000) HDL-Cholesterol, total cholesterol, and the risk of stroke in middle-aged British men. Stroke 31: 1882-1888.
18. Park J-H, Hong K-S, Lee E-J, Lee J, Kim D-E, (2011) High Levels of Apolipoprotein B/AI Ratio Are Associated With Intracranial Atherosclerotic Stenosis. Stroke 42: 3040-3046.
19. Nicholls SJ, Tuzcu EM, Sipahi I, Grasso AW, Schoenhagen P, et al. (2007) Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis. JAMA 297: 499-508.
20. Chimowitz MI, Lynn MJ, Derdeyn CP, Turan TN, Fiorella D, et al. (2011) Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med 365: 993-1003.
21. Barter P, (2005) The role of HDL-cholesterol in preventing atherosclerotic disease. Eur Heart J Suppl 7: F4-F8.
22. D'Armiento FP, Bianchi A, de Nigris F, Capuzzi DM, D'Armiento MR, et al. (2001) Age-related effects on atherogenesis and scavenger enzymes of intracranial and extracranial arteries in men without classic risk factors for atherosclerosis. Stroke 32: 2472-2478.
23. Farmer JA, Liao J, (2011) Evolving concepts of the role of high-density lipoprotein in protection from atherosclerosis. Curr Atheroscler Rep 13: 107-114.
24. Castelli WP, (1988) Cholesterol and lipids in the risk of coronary artery disease-the Framingham Heart Study. Can J Cardiol 4 Suppl A: 5A-10A.
25. Huxley RR, Barzi F, Lam TH, Czernichow S, Fang X, et al. (2011) Isolated low levels of high-density lipoprotein cholesterol are associated with an increased risk of coronary heart disease: an individual participant data meta-analysis of 23 studies in the Asia-Pacific region. Circulation 124: 2056-2064.
26. Gotto AM Jr, Brinton EA, (2004) Assessing low levels of high-density lipoprotein cholesterol as a risk factor in coronary heart disease: a working group report and update. J Am Coll Cardiol 43: 717-724.
27. Chapman MJ, Assmann G, Fruchart JC, Shepherd J, Sirtori C, (2004) Raising high-density lipoprotein cholesterol with reduction of cardiovascular risk: the role of nicotinic acid-a position paper developed by the European Consensus Panel on HDL-C. Curr Med Res Opin 20: 1253-1268.
28. Barter PJ, Caulfield M, Eriksson M, Grundy SM, Kastelein JJ, et al. (2007) Effects of torcetrapib in patients at high risk for coronary events. N Engl J Med 357: 2109-2122.
29. Ginsberg HN, Elam MB, Lovato LC, Crouse JR 3rd, Leiter LA, et al. (2010) Effects of combination lipid therapy in type 2 diabetes mellitus. N Engl J Med 362: 1563-1574.
30. Boden WE, Probstfield JL, Anderson T, Chaitman BR, Desvignes-Nickens P, et al. (2011) Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. N Engl J Med 365: 2255-2267.
31. Navab M, Reddy ST, Van Lenten BJ, Anantharamaiah GM, Fogelman AM, (2009) The role of dysfunctional HDL in atherosclerosis. J Lipid Res 50 Suppl: S145-149.
32. Smith JD, (2010) Dysfunctional HDL as a Diagnostic and Therapeutic Target. Arterioscler Thromb Vasc Biol 30: 151-155.